🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14 results for “Zentalis Pharmaceuticals” Clear

  1. Investigator's choice of Chemotherapy

    Zentalis Pharmaceuticals

    Ovarian Cancer

    phase 3 small molecule active

    1 trial

  2. Azenosertib

    Zentalis Pharmaceuticals

    Uterine Serous Carcinoma

    phase 2 small molecule active

    2 trials

  3. Azenosertib

    Zentalis Pharmaceuticals

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  4. Azenosertib

    Zentalis Pharmaceuticals

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  5. ZN-d5

    Zentalis Pharmaceuticals

    Amyloidosis

    phase 2 small molecule completed

    1 trial

  6. ZN-d5 ZN-c3

    Zentalis Pharmaceuticals

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule terminated

    1 trial

  7. Zentalis

    Zentalis Pharmaceuticals

    Advanced Pancreatic Adenocarcinoma

    phase 2 small molecule active

    1 trial

  8. azenosertib

    Zentalis Pharmaceuticals

    High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

    phase 2 small molecule active

    1 trial

  9. Azenosertib

    Zentalis Pharmaceuticals

    Solid Tumor

    phase 1 small molecule active

    2 trials

  10. Azenosertib

    Zentalis Pharmaceuticals

    Osteosarcoma

    phase 1 small molecule completed

    1 trial

  11. ZN-c3

    Zentalis Pharmaceuticals

    Tumors

    phase 1 small molecule terminated

    1 trial

  12. ZN-c3

    Zentalis Pharmaceuticals

    Metastatic Colorectal Cancer

    phase 1 small molecule terminated

    1 trial

  13. ZN-d5

    Zentalis Pharmaceuticals

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  14. ZN-d5

    Zentalis Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources